- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 8, 2025 | 35.72M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $14.5M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $18.09M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $6M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $6.36M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $6.15M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $6.54M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $16.22M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $24.98M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $16.73M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $25.6M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 35.25M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $19K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$8.8M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $21.09M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $22.57M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.08 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.08 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $3.74M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.73M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$2.79M |
| Revenue | Q1 2025 · Mar 31, 2024 | $10.69M |